45
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Study on Risk Factors for Readmission of Elderly Patients with Pulmonary Tuberculosis Within One Month Using Propensity Score Matching Method

, , , &
Pages 1625-1632 | Received 12 Jan 2024, Accepted 19 Apr 2024, Published online: 26 Apr 2024

References

  • Gupta S, Arora V, Sharma OP, et al. Prevalence & pattern of respiratory diseases including tuberculosis in elderly in ghaziabad - Delhi - NCR. Indian J Tuberc. 2016;63(4):236–241. doi:10.1016/j.ijtb.2016.09.012
  • Piergallini TJ, Turner J. Tuberculosis in the elderly: why inflammation matters. Exp Gerontol. 2018;105:32–39. doi:10.1016/j.exger.2017.12.021
  • Velayutham BRV, Nair D, Chandrasekaran V, et al. Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB control programme in South India. PLoS One. 2014;9(3):e88045. doi:10.1371/journal.pone.0088045
  • Lyon SM, Rossman MD, Schlossberg D. Pulmonary Tuberculosis. Microbiol Spectr. 2017;5(1). doi:10.1128/microbiolspec.TNMI7-0032-2016
  • Word Health Organization. Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023.
  • Hase I, Toren KG, Hirano H, et al. Pulmonary tuberculosis in older adults: increasedmort ality related to tuberculosis within two months of treatment initiation. Drugs Aging. 2021;38(9):807–815. doi:10.1007/s40266-021-00880-4
  • Zhang CY, Chen H, Zhang H, et al. Analysis of the reported incidence of pulmonary tuberculosis in the elderly aged 65 and over in China, 2011–2020. Chin J Dis Control Prevent. 2022;26(11):1252–1258.
  • Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol. 2011;11(4):289–295. doi:10.1038/nri2959
  • Byng-Maddick R, Noursadeghi M. Does tuberculosis threaten our ageing populations? BMC Infect Dis. 2016;16(1):119. doi:10.1186/s12879-016-1451-0
  • Kan T, Komiya K, Yamasue M, et al. Comparison of chest computed tomography features between pulmonary tuberculosis patients with culture-positive and culture-negative sputum for non-mycobacteria: a retrospective observational study. Medicine. 2021;100(31):e26897. doi:10.1097/MD.0000000000026897
  • Di Gennaro F, Vittozzi P, Gualano G, et al. Active pulmonary tuberculosis in elderly patients: a 2016–2019 retrospective analysis from an Italian referral hospital. Antibiotics. 2020;9(8):489. doi:10.3390/antibiotics9080489
  • Negin J, Abimbola S, Marais BJ. Tuberculosis among older adults – time to take notice. Int J Infect Dis. 2015;32:135–137. doi:10.1016/j.ijid.2014.11.018
  • Li SJ, Li YF, Song WM. Population aging and trends of pulmonary tuberculosis incidence in the elderly. BMC Infect Dis. 2021;21(1):302. doi:10.1186/s12879-021-05994-z
  • Duggal R, Zhang Y, Diana ML. The association between hospital ACO participation and readmission rates. J Healthc Manag. 2018;63(5):e100–e114. doi:10.1097/JHM-D-16-00045
  • Ye X, Su X, Shi J, et al. Incidence, causes, and risk factors for unplanned readmission in patients admitted with pulmonary tuberculosis in China. J Infect Dev Ctries. 2023;17(7):1007–1013. doi:10.3855/jidc.17190
  • Cao J, Liu S, Huang J. Risk factor for 31-day unplanned readmission to hospital in patients with pulmonary tuberculosis in China. Saudi Med J. 2021;42(9):1017–1023. doi:10.15537/smj.2021.42.9.20210281
  • Anaam MS, Alrasheedy AA, Alsahali S, et al. Rate and risk factors of recurrent tuberculosis in Yemen: a 5-year prospective study. Infect Dis. 2020;52(3):161–169. doi:10.1080/23744235.2019.1690162
  • Finlayson K, Chang AM, Courtney MD, et al. Transitional care interventions reduce unplanned hospital readmissions in high-risk older adults. BMC Health Serv Res. 2018;18(1):956. doi:10.1186/s12913-018-3771-9
  • Daras LC, Deutsch A, Ingber MJ, et al. Inpatient rehabilitation facilities’ hospital readmission rates for medicare beneficiaries treated following a stroke. Top Stroke Rehabil. 2021;28(1):61–71. doi:10.1080/10749357.2020.1771927
  • Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology. 2019;156(8):2230–2241.e11. doi:10.1053/j.gastro.2019.02.002
  • Zhang Z, Cao L, Chen R, et al. Electronic healthcare records and external outcome data for hospitalized patients with heart failure. Sci Data. 2021;8(1):46. doi:10.1038/s41597-021-00835-9
  • Huang J, Yin H, Zhang M, et al. Understanding the economic burden of heart failure in China: impact on disease management and resource utilization. J Med Econ. 2017;20(5):549–553. doi:10.1080/13696998.2017.1297309
  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease- A systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.0158765
  • Igari H, Imasawa T, Noguchi N, et al. Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis. J Infect Chemother. 2015;21(8):559–563. doi:10.1016/j.jiac.2015.04.008
  • Natarajan A, Beena PM, Devnikar AV, et al. A systemic review on tuberculosis. Indian J Tuberc. 2020;67(3):295–311. doi:10.1016/j.ijtb.2020.02.005
  • Pang Y, An J, Shu W, et al. Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017. Emerg Infect Dis. 2019;25(3):457–464. doi:10.3201/eid2503.180572
  • Xu ZH, Liu LQ, Wang QZ, et al. Study on epidemiological characteristics and influencing factors of pathogen positive hospitalized pulmonary tuberculosis patients with extrapulmonary tuberculosis. Chin J Antitubercul. 2021;43(11):1164–1170.